Skip to content

Author

Hye Sun Lee

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Cardiovascular risk associated with first-line Janus kinase inhibitors versus TNF inhibitors in patients with RA: a nationwide cohort study.

First-line use of JAKi was not associated with an increased risk of MACE compared with TNFi, providing real-world evidence supporting the cardiovascular safety of JAKi as first-line advanced therapy in patients with RA.

O. C. Kwon, Hye Sun Lee, S. Jeon et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.